For treating diabetes and its related complications, an estimated USD 1123 billion was spent globally in 2019. The cost has been projected to be USD 1308 billion by 20451 . More than 87% of the diabetes related deaths occur in low and middle-income countries, though only 35% of total diabetes-related health expenditure is spent here. Moreover, compared to people living in high-income countries, people in these countries have a lack of access to health insurance or publicly available medical services. Thus, they pay a larger share of out-of-pocket health expenditures. Bangladesh, like many developing countries is struggling to cope with this epidemic due to inadequate infrastructure for diabetes care. It is one of the world’s lowest spending countries in health sector and most of the people are deprived from health insurance, making the health service mostly unaffordable. According to the Bangladesh National Health Accounts, in 2010, Bangladesh spent USD 2.3 billion on health (or USD 16.2 per person per year) and 64% of this cost came from out of pocket payments. However, according to the World Health Organization (WHO), in 2014, Bangladesh spent USD 88 per person per year on health. It has been observed that, on average, a household spent 7.5% of its total income on receiving health care, with the poorest 20% of the households spending approximately 13.5% of their income on it. The per capita gross domestic product (GDP) of Bangladesh was USD 1677 in 2018, and nearly one-third of the population in the country was below the poverty line. Hence, the out of pocket health care expenditure posed a notable economic burden on the Bangladeshi population.